Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Oncotarget
|
June 28, 2014
Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model
Gaoya Xu, Weidan Ji, Yinghan Su, et al.
Molecular Cancer Research : MCR
|
March 18, 2008
Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy
Changqing Su, Manli Na, Jie Chen, et al.
Cancer Letters
|
May 21, 2013
MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
Longlong Bao, Yan Yan, Can Xu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 16, 2008
Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates
Changqing Su, Hui Cao, Shuping Tan, et al.
Oncotarget
|
December 5, 2014
Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models
Huanzhang Hu, Yinghe Qiu, Minggao Guo, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2022
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
Yinghan Su, Jiang Li, Weidan Ji, et al.
Cancer Letters
|
April 3, 2018
Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma
Haisen Yin, Risheng Que, Chunying Liu, et al.
Molecular Cancer Therapeutics
|
June 21, 2008
A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers
Xinghua Wang, Changqing Su, Hui Cao, et al.
Molecular Cancer Therapeutics
|
June 6, 2008
Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey
Jie Chen, Changqing Su, Qiujun Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2006
Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice
Changqing Su, Linhui Peng, Jonathan Sham, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Oncotarget
|
June 28, 2014
Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model
Gaoya Xu, Weidan Ji, Yinghan Su, et al.
Molecular Cancer Research : MCR
|
March 18, 2008
Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy
Changqing Su, Manli Na, Jie Chen, et al.
Cancer Letters
|
May 21, 2013
MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
Longlong Bao, Yan Yan, Can Xu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
August 16, 2008
Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates
Changqing Su, Hui Cao, Shuping Tan, et al.
Oncotarget
|
December 5, 2014
Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models
Huanzhang Hu, Yinghe Qiu, Minggao Guo, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2022
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
Yinghan Su, Jiang Li, Weidan Ji, et al.
Cancer Letters
|
April 3, 2018
Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma
Haisen Yin, Risheng Que, Chunying Liu, et al.
Molecular Cancer Therapeutics
|
June 21, 2008
A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers
Xinghua Wang, Changqing Su, Hui Cao, et al.
Molecular Cancer Therapeutics
|
June 6, 2008
Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey
Jie Chen, Changqing Su, Qiujun Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2006
Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice
Changqing Su, Linhui Peng, Jonathan Sham, et al.
Page
of 10